FAM242D

Across TCGA pan-cancer cohorts, FAM242D RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated FAM242D data layer.

The strongest signal is observed in mesothelioma (MESO), where higher FAM242D RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FAM242D expression acts as an unfavorable survival marker, although some lineages such as PAAD and LGG show a favorable association.

MESO, UCEC, and BLCA are the cancer types where FAM242D RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.069	0.580	<.001	108	view →
UCEC	DFS	Tertile	All	0.623	0.848	<.001	96	view →
BLCA	DFS	Tertile	All	0.144	0.627	<.001	72	view →
LIHC	OS	Tertile	All	0.129	0.707	<.001	54	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	51	view →
LAML	DFS	Tertile	All	0.112	0.582	.010	18	view →
PAAD	OS	Tertile	II,III,IV	1.000	0.365	.041	9	view →
HNSC	DFS	Tertile	III,IV	0.346	0.626	.040	6	view →
LGG	DFS	Tertile	All	0.781	0.373	.037	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

FAM242D–MESO (OS)

Open the MESO breakdown →